Clinical NGS Data Analysis Software - NGeneAnalySys

● Product Introduction - NGeneAnalySysTM

 

NGeneBio clinical NGS analysis SW platform. 

It provides accurate pathogenic variants information based on ACMG guideline and relevant therapy information based on databases (solid tumor / hematologic malignancies), which enables efficient on-site data analysis for clinical NGS.

 

• Clinical SW for NGS diagnostics 
• GMP/ISO13485 certified 
• Korea MFDS IVD (KFDA class II) approved (Dec/2017); 
• combined with BRCAaccuTest
• CE-IVD marked (Jun/2017)
• Integrated DBs for clinical significance & relevant drug information provided 

 

 

● Features

Advanced analytical platform

• Compliance with ACMG guideline for NGS clinical use
• Provides tier-based reporting with therapeutic drug information and clinical trials
• Detected variants list with detailed information and visual charts

Accurate interpretation

: Recent databases employed and In Silico prediction

• Reference sequence DB
• Population DB
• Cancer specific DB
• Constitutional variant DB
• Internal DB

Create Report

• Provides QC report on sample data and clinical report of variants analysis

Easy analysis

• From data uploading to analysis result by one UI operation

 

Information 

• NGeneAnalysys V.1.1 is compatible with NGeneBio BRCAaccuTest
• NGeneAnalysys V.1.3 is compatible with NGeneBio all clinical NGS kits (BRCAaccuTest/BRCAaccuTestPLUS/SOLIDaccuTest/HEMEaccuTest) and Illumina TruSight Tumor 170